MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.010
-0.040 (-1.31%)
At close: Apr 28, 2026, 4:00 PM EDT
3.040
+0.030 (1.00%)
After-hours: Apr 28, 2026, 7:42 PM EDT
MacroGenics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for MacroGenics stock have an average target of 5.00, with a low estimate of 2.00 and a high estimate of 9.00. The average target predicts an increase of 66.11% from the current stock price of 3.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MacroGenics stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $4 → $6 | Buy | Maintains | $4 → $6 | +99.34% | Apr 20, 2026 |
| B. Riley Securities | B. Riley Securities | Hold → Strong Buy Upgrades $3 → $9 | Hold → Strong Buy | Upgrades | $3 → $9 | +199.00% | Apr 10, 2026 |
| Barclays | Barclays | Buy Maintains $3 → $4 | Buy | Maintains | $3 → $4 | +32.89% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | -33.55% | Nov 3, 2025 |
| Barclays | Barclays | Buy Initiates $3 | Buy | Initiates | $3 | -0.33% | Sep 17, 2025 |
Financial Forecast
Revenue This Year
77.40M
from 149.50M
Decreased by -48.23%
Revenue Next Year
79.87M
from 77.40M
Increased by 3.19%
EPS This Year
-2.02
from -1.18
EPS Next Year
-1.62
from -2.02
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 139.4M | 103.3M | ||||||
| Avg | 77.4M | 79.9M | ||||||
| Low | 10.8M | 58.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -6.7% | 33.5% | ||||||
| Avg | -48.2% | 3.2% | ||||||
| Low | -92.8% | -24.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.05 | -1.02 | |||
| Avg | -2.02 | -1.62 | |||
| Low | -2.74 | -2.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.